Cargando…
Intranasal, siRNA Delivery to the Brain by TAT/MGF Tagged PEGylated Chitosan Nanoparticles
Neurodegeneration is characterized by progressive loss of structure and function of neurons. Several therapeutic methods and drugs are available to alleviate the symptoms of these diseases. The currently used delivery strategies such as implantation of catheters, intracarotid infusions, surgeries, a...
Autores principales: | Malhotra, Meenakshi, Tomaro-Duchesneau, Catherine, Saha, Shyamali, Prakash, Satya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590831/ https://www.ncbi.nlm.nih.gov/pubmed/26555995 http://dx.doi.org/10.1155/2013/812387 |
Ejemplares similares
-
Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA
por: Malhotra, Meenakshi, et al.
Publicado: (2013) -
Systemic siRNA Delivery via Peptide-Tagged Polymeric Nanoparticles, Targeting PLK1 Gene in a Mouse Xenograft Model of Colorectal Cancer
por: Malhotra, Meenakshi, et al.
Publicado: (2013) -
A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis
por: Malhotra, Meenakshi, et al.
Publicado: (2011) -
Microencapsulation for the Therapeutic Delivery of Drugs, Live Mammalian and Bacterial Cells, and Other Biopharmaceutics: Current Status and Future Directions
por: Tomaro-Duchesneau, Catherine, et al.
Publicado: (2013) -
The Gut Microbiota and Human Health with an Emphasis on the Use of Microencapsulated Bacterial Cells
por: Prakash, Satya, et al.
Publicado: (2011)